BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11181475)

  • 1. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits.
    Fukumoto Y; Libby P; Rabkin E; Hill CC; Enomoto M; Hirouchi Y; Shiomi M; Aikawa M
    Circulation; 2001 Feb; 103(7):993-9. PubMed ID: 11181475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
    Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro.
    Aikawa M; Rabkin E; Sugiyama S; Voglic SJ; Fukumoto Y; Furukawa Y; Shiomi M; Schoen FJ; Libby P
    Circulation; 2001 Jan; 103(2):276-83. PubMed ID: 11208689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins.
    Shiomi M; Ito T; Hirouchi Y; Enomoto M
    Atherosclerosis; 2001 Jul; 157(1):75-84. PubMed ID: 11427206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins.
    Hofnagel O; Luechtenborg B; Eschert H; Weissen-Plenz G; Severs NJ; Robenek H
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):604-10. PubMed ID: 16373606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of atheromatous plaque affected by lesional composition: study of WHHL rabbits treated with statins.
    Shiomi M; Ito T; Hirouchi Y; Enomoto M
    Ann N Y Acad Sci; 2001 Dec; 947():419-23. PubMed ID: 11795305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
    Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
    Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition.
    Bandoh T; Mitani H; Niihashi M; Kusumi Y; Kimura M; Ishikawa J; Totsuka T; Sakurai I; Hayashi S
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):136-44. PubMed ID: 10630744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
    Shiomi M; Ito T; Tsukada T; Yata T; Watanabe Y; Tsujita Y; Fukami M; Fukushige J; Hosokawa T; Tamura A
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1938-44. PubMed ID: 7583574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.
    Sakamoto K; Mikami H; Kimura J
    Br J Pharmacol; 2008 Aug; 154(7):1482-90. PubMed ID: 18500364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
    Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of statins on the vascular wall.
    Corsini A; Pazzucconi F; Arnaboldi L; Pfister P; Fumagalli R; Paoletti R; Sirtori CR
    J Cardiovasc Pharmacol; 1998 May; 31(5):773-8. PubMed ID: 9593078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dosage statins reduce choroidal damage in hypercholesterolemic rabbits.
    Rojas B; Ramírez AI; Salazar JJ; de Hoz R; Redondo A; Raposo R; Mendez T; Tejerina T; Triviño A; Ramírez JM
    Acta Ophthalmol; 2011 Nov; 89(7):660-9. PubMed ID: 20064114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery.
    Bandoh T; Mitani H; Niihashi M; Kusumi Y; Ishikawa J; Kimura M; Totsuka T; Sakurai I; Hayashi S
    Eur J Pharmacol; 1996 Nov; 315(1):37-42. PubMed ID: 8960862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
    Luan Z; Chase AJ; Newby AC
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin normalizes the decreased turnovers of glutathione and ascorbic acid in Watanabe heritable hyperlipidaemic rabbits.
    Suzumura K; Kasahara E; Ohnishi Y; Chien KC; Inoue M
    Clin Exp Pharmacol Physiol; 2000 Sep; 27(9):709-14. PubMed ID: 10972538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.
    Soma MR; Donetti E; Parolini C; Mazzini G; Ferrari C; Fumagalli R; Paoletti R
    Arterioscler Thromb; 1993 Apr; 13(4):571-8. PubMed ID: 8466892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages.
    Bellosta S; Via D; Canavesi M; Pfister P; Fumagalli R; Paoletti R; Bernini F
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1671-8. PubMed ID: 9812903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.